Ogino Daisuke, Takahashi Kunihiko, Sato Hajime
Department of Health Policy and Technology Assessment, National Institute of Public Health, 2-3-6 Minami, Wako, Saitama 351-0197, Japan.
Trials. 2014 Nov 5;15:428. doi: 10.1186/1745-6215-15-428.
It is well known that information about clinical trials is not easily accessible by the public. In Japan, clinical trial information can be accessed by the general public through online registries; however, many people find these registries difficult to use. To improve current clinical trial registries, we propose that combining them with clinical information phrased in lay terms would be beneficial to other interested professionals such as journalists and clinicians, as well as the general public. Therefore, this study aimed to examine the current pattern of distribution of clinical trial information from the primary World Health Organization (WHO) registries. Based on the results of this assessment, we then aimed to build and evaluate a prototype of the Japan Primary Registries Network (JPRN) portal that would be easily accessible to patients and the public, while still remaining useful for professionals.
We assessed a total of 14 primary clinical trial registries listed on the WHO International Clinical Trials Registry Platform between January and February 2013. Website content was accessed and checked against a series of items that looked at usability, communication, design and accessibility of the sites. We excluded registries that were not active or were not on the approved WHO registry list at the time of our assessment. We also examined only the English versions of the websites as native-language registries may offer more functionality or different content than the English version of the same website.
All registries examined had a function allowing users to search the registry data and that displayed the related information from the search, including the clinical trial registration data. However, few websites were found to be user-friendly, and there was little integration with social media.
We confirmed that there are few websites providing useful clinical trial information to patients and their families. However, information gleaned from some of the more advanced online registries could be used to improve the content and functionality of the JPRN portal.
众所周知,公众不易获取临床试验信息。在日本,公众可通过在线注册库获取临床试验信息;然而,许多人发现这些注册库难以使用。为改进当前的临床试验注册库,我们提议将其与用通俗易懂的语言表述的临床信息相结合,这将对记者和临床医生等其他相关专业人员以及公众有益。因此,本研究旨在考察世界卫生组织(WHO)主要注册库中临床试验信息的当前分布模式。基于这一评估结果,我们随后旨在构建并评估日本主要注册库网络(JPRN)门户网站的原型,该网站既要方便患者和公众访问,同时对专业人员仍有用处。
2013年1月至2月期间,我们评估了WHO国际临床试验注册平台上列出的总共14个主要临床试验注册库。访问网站内容,并对照一系列考察网站可用性、沟通性、设计和可访问性的项目进行检查。我们排除了在评估时不活跃或未列入WHO批准的注册库名单的注册库。我们还仅检查了网站的英文版本,因为母语版本的注册库可能比同一网站的英文版本提供更多功能或不同内容。
所有被检查的注册库都有一个允许用户搜索注册库数据的功能,并显示搜索的相关信息,包括临床试验注册数据。然而,发现很少有网站对用户友好,并且与社交媒体的整合也很少。
我们确认,很少有网站向患者及其家属提供有用的临床试验信息。然而,从一些更先进的在线注册库收集的信息可用于改进JPRN门户网站的内容和功能。